Parenteral product quality is improving. Since 2014, when USP <790> “Visible Particulates in Injections” (1) became official, particle-related recalls of injectable products have dropped significantly ...
Final product inspection results should be included as part of the batch release documentation, says Susan J. Schniepp, distinguished fellow at Nelson Laboratories, LLC. A: This is not a new problem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results